ANIK
Anika Therapeutics Inc
19.20$
-1.5%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -91.7% | 21.7% | 24.5% | 5.9% | -11.5% | -38.1% | 2.5% | 13.1% | 90.0% | 21.6% | 7.5% | 14.6% | 9.5% | 7.7% | 14.1% | 15.7% | 14.8% | 33.5% | 37.9% | 42.0% | 23.0% | 36.0% | 33.1% | 32.3% | 10.0% | 5.7% | 2.8% | -1.5% | 4.5% | 9.9% | |
| 50.0% | 2.5% | 5.8% | 8.1% | 7.3% | 10.9% | 8.3% | 6.5% | 2.7% | 1.5% | 1.4% | 2.7% | 4.0% | 3.2% | 6.0% | 6.2% | 6.3% | 6.4% | 4.5% | 4.1% | 3.6% | 3.8% | 5.6% | 5.2% | 11.5% | 9.7% | 9.3% | 11.8% | 6.8% | 5.1% | |
| – | – | – | – | – | – | – | – | – | – | 4,721.2% | 2,957.3% | 3.9% | 2.4% | 2.0% | 1.8% | 1.6% | 1.7% | 1.5% | 2.4% | 3.3% | 5.1% | 10.5% | 5.3% | 4.1% | 7.5% | 9.2% | 12.6% | 11.0% | 8.9% | |
| – | – | – | – | – | – | – | 0.4% | – | – | 1.9% | 2.7% | 0.2% | – | – | 7.6% | 5.9% | 3.6% | -6.5% | 1.7% | 3.3% | 6.2% | 12.8% | 8.1% | 18.7% | -2.4% | 9.4% | – | – | – | |
| 41.7% | -10.0% | -13.7% | -11.1% | -20.3% | 9.6% | 17.2% | 1.2% | 84.8% | -10.1% | -16.6% | -11.3% | -9.2% | -12.2% | -6.8% | -10.7% | -13.3% | -3.9% | 3.6% | 3.2% | -15.3% | -2.1% | -3.0% | -5.8% | -10.3% | -10.0% | -7.6% | -10.0% | -10.9% | -0.7% | |
| 33.3% | 2.5% | 15.8% | 12.6% | 3.1% | 8.0% | 0.7% | 1.7% | 1.8% | 5.4% | 4.9% | 47.9% | 45.4% | 9.9% | 5.0% | 2.2% | 2.1% | 0.6% | 1.5% | 9.9% | 13.6% | 7.9% | 4.4% | 2.5% | 1.2% | 3.5% | 4.8% | 4.5% | 6.4% | 6.1% | |
| – | -3.3% | -103.6% | -27.4% | 19.4% | 45.2% | 12.2% | 9.6% | 1.3% | -5.4% | -4.9% | -59.3% | -35.8% | -50.4% | -4.8% | -2.2% | -2.1% | -0.3% | -7.9% | -32.5% | -6.5% | -11.0% | -47.6% | 34.6% | -54.6% | -2.1% | -4.8% | -4.5% | -7.0% | -0.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | 83,817.2% | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | 1.0% | 0.4% | 0.2% | – | – | – | |
| – | – | -14.4% | -14.4% | – | – | – | – | – | – | – | – | – | 41,908.6% | – | 0.2% | 0.5% | 4.1% | -6.0% | 1.2% | -24.2% | 0.3% | -28.4% | -26.2% | -0.2% | -0.3% | -0.6% | -4.1% | -9.1% | -8.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -2.5% | -2.2% | -12.8% | – | – | – | -0.5% | -0.5% | -0.5% | -0.3% | -0.1% | -0.2% | 0.0% | 0.0% | – | |
| 16.7% | 147.5% | -7.2% | -10.4% | 3.3% | 4.8% | – | 0.6% | 2.2% | 1.9% | 6.4% | 8.2% | 46.6% | -4.1% | -2.4% | -1.8% | -1.1% | -7.6% | 5.0% | 2.1% | -22.6% | 0.3% | -27.4% | -7.1% | -2.9% | -4.6% | -3.1% | -5.2% | -10.6% | -9.4% | |
| -75.0% | 165.8% | -86.3% | -31.9% | 11.2% | 7.1% | 14.7% | 23.3% | 93.5% | 18.1% | 9.0% | -36.5% | 20.4% | -46.8% | 6.8% | 11.7% | 11.6% | 25.7% | 34.9% | 11.3% | -6.2% | 25.6% | -41.9% | 59.7% | -47.3% | -1.0% | -5.2% | -11.1% | -13.1% | 0.3% | |
| -91.7% | 19.2% | 8.6% | -6.7% | -14.6% | -46.2% | 1.8% | 11.4% | 88.2% | 16.3% | 2.6% | -33.3% | -35.9% | -2.2% | 9.1% | 13.5% | 12.7% | 32.9% | 36.4% | 32.1% | 9.5% | 28.1% | 28.7% | 29.8% | 8.8% | 2.2% | -2.0% | -6.0% | -1.9% | 3.9% |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.